About: Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $6.18 (-1.12%)
ACET NASDAQ Adicet Bio Inc
Adicet Bio Inc share price
ACET price activity
Último preço
$ 6,250
Variação (24h)
-0,22 USD (-3,40%)
Volume
135K
Volume (média 4 sem.)
-
Abertura
$ 6,52
Variação do dia
$ 6,21 - $ 6,55
Fechamento anterior
$ 6,47
Último negócio
06 Oct, 8:00 pm GMT+0
Atrasado
06 Oct, 8:00 pm GMT+0
ACET price performance
Atrasado
06 Oct, 8:00 pm GMT+0
quote.marketSignals